ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Time-restricted feeding's effect on overweight and obese patients with chronic kidney disease stages 3-4: A prospective non-randomized control pilot study

Lao, Bei-ni; Luo, Jiang-hong; Xu, Xue-yi; Fu, Li-zhe; Tang, Fang; Ouyang, Wen-wei; Xu, Xin-zhu; Wei, Meng-ting; Xiao, Bing-jie; Chen, Lin-yi; Wu, Yi-fan*; Liu, Xu-sheng*广东省人民医院; 广州中医药大学
Frontiers in Endocrinology2023-3-22DOI: 10.3389/fendo.2023.1096093
2被引11阅读
引用收藏
分享

摘要

BackgroundTime-restricted feeding (TRF) has become a popular weight loss method in recent years. It is widely used in the nutritional treatment of normal obese people and obese people with chronic diseases such as diabetes mellitus and hypertension, and has shown many benefits. However, most TRF studies have excluded chronic kidney disease (CKD) patients, resulting in a lack of sufficient evidence-based practice for the efficacy and safety of TRF therapy for CKD. Therefore, we explore the efficacy and safety of TRF in overweight and obese patients with moderate-to-severe stage CKD through this pilot study, and observe patient compliance to assess the feasibility of the therapy. MethodsThis is a prospective, non-randomized controlled short-term clinical trial. We recruited overweight and obese patients with CKD stages 3-4 from an outpatient clinic and assigned them to either a TRF group or a control diet (CD) group according to their preferences. Changes in renal function, other biochemical data, anthropometric parameters, gut microbiota, and adverse events were measured before the intervention and after 12 weeks. ResultsThe change in estimated glomerular filtration rate (eGFR) before and after intervention in the TRF group (Delta = 3.1 +/- 5.3 ml/min/1.73m(2)) showed significant improvement compared with the CD group (Delta = -0.8 +/- 4.4 ml/min/1.73m(2)). Furthermore, the TRF group had a significant decrease in uric acid (Delta = -70.8 +/- 124.2 mu mol/L), but an increase in total protein (Delta = 1.7 +/- 2.5 g/L), while the changes were inconsistent for inflammatory factors. In addition, the TRF group showed a significant decrease in body weight (Delta = -2.8 +/- 2.9 kg) compared to the CD group, and body composition indicated the same decrease in body fat mass, fat free mass and body water. Additionally, TRF shifted the gut microbiota in a positive direction. ConclusionPreliminary studies suggest that overweight and obese patients with moderate-to-severe CKD with weight loss needs, and who were under strict medical supervision by healthcare professionals, performed TRF with good compliance. They did so without apparent adverse events, and showed efficacy in protecting renal function. These results may be due to changes in body composition and alterations in gut microbiota.

学科与关键词

关键词
obesitychronic kidney diseasetime-restricted feedingTRFrenal function
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Endocrinology
发表日期
2023-03-22
卷期
第 14 卷
页码
1096093
DOI
10.3389/fendo.2023.1096093
成果收录
SCIE

作者

  • L

    Lao, Bei-ni (第一作者)

    2 · guangdong prov hosp · guangzhou univ chinese med

  • L

    Luo, Jiang-hong

    2 · guangdong prov hosp · guangzhou univ chinese med

查看全部 12 位作者收起作者
  • X

    Xu, Xue-yi

    2 · guangdong prov hosp · guangzhou univ chinese med

  • F

    Fu, Li-zhe

    2 · guangdong prov hosp · guangzhou univ chinese med

  • T

    Tang, Fang

    2 · guangdong prov hosp · guangzhou univ chinese med

  • O

    Ouyang, Wen-wei

    2 · guangdong prov hosp · guangzhou univ chinese med

  • X

    Xu, Xin-zhu

    2 · guangdong prov hosp · guangzhou univ chinese med

  • W

    Wei, Meng-ting

    2 · guangdong prov hosp · guangzhou univ chinese med

  • X

    Xiao, Bing-jie

    2 · guangdong prov hosp · guangzhou univ chinese med

  • C

    Chen, Lin-yi

    2 · guangdong prov hosp · guangzhou univ chinese med

  • W

    Wu, Yi-fan (通讯)

    2 · guangdong prov hosp · guangzhou univ chinese med

  • L

    Liu, Xu-sheng (通讯)

    2 · guangdong prov hosp · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417